Neuroimaging in Alcohol and Drug Dependence

Current Behavioral Neuroscience Reports

Volumn 1, Issue 1, 2014, Pages 45-54

  Niciu, Mark J ^a   Mason, Graeme F ^b,c  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b YALE UNIVERSITY   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alcoholism; Brain; Cocaine; Ethanol; Heroin; Marijuana; Metabolism; Methamphetamine; MRI; MRS; Opioids; PET; Psychostimulants

Indexed keywords

EID: 84926498677     PISSN: None     EISSN: 21962979     Source Type: Journal    
DOI: 10.1007/s40473-013-0005-7     Document Type: Article

References (111)

1. Buhler M, Mann K. Alcohol and the human brain: a systematic review of different neuroimaging methods. Alcohol Clin Exp Res. 2011;35:1771–93.
2. Weerts EM, Wand GS, Kuwabara H, et al. Positron emission tomography imaging of mu- and delta-opioid receptor binding in alcohol-dependent and healthy control subjects. Alcohol Clin Exp Res. 2011;35:2162–73.
3. Spreckelmeyer KN, Paulzen M, Raptis M, et al. Opiate-induced dopamine release is modulated by severity of alcohol dependence: an [(18)F]fallypride positron emission tomography study. Biol Psychiatry. 2011;70:770–6.
4. Lingford-Hughes A, Reid AG, Myers J, et al. A [11C] Ro15 4513 PET study suggests that alcohol dependence in man is associated with reduced alpha5 benzodiazepine receptors in limbic regions. J Psychopharmacol. 2012;26:273–81.
5. Neumeister A, Normandin MD, Murrough JW, et al. Positron emission tomography shows elevated cannabinoid CB1 receptor binding in men with alcohol dependence. Alcohol Clin Exp Res. 2012;36:2104–9.
6. Hirvonen J, Zanotti-Fregonara P, Umhau JC, et al. Reduced cannabinoid CB1 receptor binding in alcohol dependence measured with positron emission tomography. Mol Psychiatry. 2013;18:916–21.
7. Momenan R, Steckler LE, Saad ZS, et al. Effects of alcohol dependence on cortical thickness as determined by magnetic resonance imaging. Psychiatry Res. 2012;204:101–11.
8. Kroenke CD, Rohlfing T, Park B, et al. Monkeys that voluntarily and chronically drink alcohol damage their brains: a longitudinal MRI study. Neuropsychopharmacology 2013.
9. Zahr NM, Kaufman KL, Harper CG. Clinical and pathological features of alcohol-related brain damage. Nat Rev Neurol. 2011;7:284–94.
10. Schulte T, Müller-Oehring E, Sullivan E, et al. White matter fiber compromise contributes differentially to attention and emotion processing impairment in alcoholism, HIV-infection, and their comorbidity. Neuropsychologia. 2012;50(12):2812–22.
11. Alhassoon OM, Sorg SF, Taylor MJ, et al. Callosal white matter microstructural recovery in abstinent alcoholics: a longitudinal diffusion tensor imaging study. Alcohol Clin Exp Res. 2012;36:1922–31.
12. Vollstädt‐Klein S, Loeber S, Richter A, et al. Validating incentive salience with functional magnetic resonance imaging: association between mesolimbic cue reactivity and attentional bias in alcohol‐dependent patients. Addict Biol. 2012;17:807–16.
13. Krienke UJ, Nikesch F, Spiegelhalder K, et al. Impact of alcohol-related video sequences on functional MRI in abstinent alcoholics. Eur Addict Res. 2013;20:33–40.
14. Schacht JP, Anton RF, Myrick H. Functional neuroimaging studies of alcohol cue reactivity: a quantitative meta-analysis and systematic review. Addict Biol. 2013;18:121–33.
15. Bednarski SR, Erdman E, Luo X, et al. Neural processes of an indirect analog of risk taking in young nondependent adult alcohol drinkers-an FMRI study of the stop signal task. Alcohol Clin Exp Res. 2012;36:768–79.
16. Beltz AM, Gates KM, Engels AS, et al. Changes in alcohol-related brain networks across the first year of college: a prospective pilot study using fMRI effective connectivity mapping. Addict Behav. 2013;38:2052–9.
17. Blaine S, Claus E, Harlaar N, et al. TACR1 genotypes predict fMRI response to alcohol cues and level of alcohol dependence. Alcohol Clin Exp Res. 2013;37 Suppl 1:E125–30.
18. Langosch JM, Spiegelhalder K, Jahnke K, et al. The impact of acamprosate on cue reactivity in alcohol dependent individuals: a functional magnetic resonance imaging study. J Clin Psychopharmacol. 2012;32:661–5.
19. Umhau JC, Momenan R, Schwandt ML, et al. Effect of acamprosate on magnetic resonance spectroscopy measures of central glutamate in detoxified alcohol-dependent individuals: a randomized controlled experimental medicine study. Arch Gen Psychiatry. 2010;67:1069–77.
20. Lukas SE, Lowen SB, Lindsey KP, et al. Extended-release naltrexone (XR-NTX) attenuates brain responses to alcohol cues in alcohol-dependent volunteers: a bold FMRI study. Neuroimage. 2013;78:176–85.
21. Thoma R, Mullins P, Ruhl D, et al. Perturbation of the glutamate-glutamine system in alcohol dependence and remission. Neuropsychopharmacology. 2011;36:1359–65.
22. Bauer J, Pedersen A, Scherbaum N, et al. Craving in alcohol-dependent patients after detoxification is related to glutamatergic dysfunction in the nucleus accumbens and the anterior cingulate cortex. Neuropsychopharmacology. 2013;38:1401–8.
23. Abé C, Mon A, Hoefer ME, et al. Metabolic abnormalities in lobar and subcortical brain regions of abstinent polysubstance users: Magnetic Resonance Spectroscopic Imaging. Alcohol Alcohol. 2013;48:543–51.
24. Hermann D, Weber-Fahr W, Sartorius A, et al. Translational magnetic resonance spectroscopy reveals excessive central glutamate levels during alcohol withdrawal in humans and rats. Biol Psychiatry. 2012;71:1015–21.
25. Gomez R, Behar KL, Watzl J, et al. Intravenous ethanol infusion decreases human cortical γ-aminobutyric acid and N-acetylaspartate as measured with proton magnetic resonance spectroscopy at 4 Tesla. Biol Psychiatry. 2012;71:239–46.
26. Volkow ND, Wang GJ, Franceschi D, et al. Low doses of alcohol substantially decrease glucose metabolism in the human brain. Neuroimage. 2006;29:295–301.
27. Volkow ND, Kim SW, Wang GJ, et al. Acute alcohol intoxication decreases glucose metabolism but increases acetate uptake in the human brain. Neuroimage. 2013;64:277–83.
28. Jiang L, Gulanski BI, De Feyter HM, et al. Increased brain uptake and oxidation of acetate in heavy drinkers. J Clin Invest. 2013;123:1605–14. These references together demonstrate that heavy drinkers possess a greater ability to oxidize acetate than light drinkers do. It may be that chronic heavy drinking leads the brain to become dependent on acetate, either for its energy or for metabolic byproducts of its oxidation, like adenosine.
29. 13C] ethanol in the rat brain after chronic ethanol exposure. J Neurochem. 2013;127:353–64.
30. Pawlosky RJ, Kashiwaya Y, Srivastava S, et al. Alterations in brain glucose utilization accompanying elevations in blood ethanol and acetate concentrations in the rat. Alcohol Clin Exp Res. 2010;34:375–81.
31. Wang J, Du H, Jiang L, et al. Oxidation of ethanol in the rat brain and effects associated with chronic ethanol exposure. Proc Natl Acad Sci. 2013;110:14444–9. The demonstration that living, intact brain oxidizes ethanol provides feasibility data for the concept of ethanol’s breakdown product, acetaldehyde, serving as an intracerebral reward.
32. Deehan GA, Engleman EA, Ding ZM, et al. Microinjections of acetaldehyde or salsolinol into the posterior ventral tegmental area increase dopamine release in the nucleus accumbens shell. Alcohol Clin Exp Res. 2012;37:722–9.
33. Karahanian E, Quintanilla ME, Tampier L, et al. Ethanol as a prodrug: brain metabolism of ethanol mediates its reinforcing effects. Alcohol Clin Exp Res. 2011;35:606–12.
34. Derr RF, Draves K, Derr M. Abatement by acetate of an ethanol withdrawal syndrome. Life Sci. 1981;29:1787–90.
35. Carmichael FJ, Israel Y, Crawford M, et al. Central nervous system effects of acetate: contribution to the central effects of ethanol. J Pharmacol Exp Ther. 1991;259:403–8.
36. 11C]-(+)-PHNO PET study in humans. Neuropsychopharmacology 2013.
37. Brody AL, Mandelkern MA, Olmstead RE, et al. Ventral striatal dopamine release in response to smoking a regular vs a denicotinized cigarette. Neuropsychopharmacology. 2009;34:282–9.
38. 11C]-(+)-PHNO PET study. PLoS One. 2013;8:e60382.
39. Domino EF, Ni L, Domino JS, et al. Denicotinized versus average nicotine tobacco cigarette smoking differentially releases striatal dopamine. Nicotine Tobacco Res. 2013;15:11–21.
40. Brody AL, Mandelkern MA, Costello MR, et al. Brain nicotinic acetylcholine receptor occupancy: effect of smoking a denicotinized cigarette. Int J Neuropsychopharmacol. 2009;12:305–16.
41. Brody AL, Mandelkern MA, London ED, et al. Effect of secondhand smoke on occupancy of nicotinic acetylcholine receptors in brain. Arch Gen Psychiatry. 2011;68:953–60.
42. 18 F-AZAN, a radioligand with improved brain kinetics. J Nucl Med. 2012;53:121–9.
43. 18 F-AZAN, a radioligand with optimal brain kinetics. J Nucl Med. 2013;54:1308–14.
44. 11C] ABP688 positron emission tomography. Proc Natl Acad Sci U S A. 2013;110:737–42.
45. Hulka L, Treyer V, Scheidegger M, et al. Smoking but not cocaine use is associated with lower cerebral metabotropic glutamate receptor 5 density in humans. Molecular psychiatry 2013.
46. Claus ED, Blaine SK, Filbey FM, et al. Association between nicotine dependence severity, BOLD response to smoking cues, and functional connectivity. Neuropsychopharmacology. 2013;38(12):2363–72.
47. Falcone M, Wileyto EP, Ruparel K, et al. Age-related differences in working memory deficits during nicotine withdrawal. Addiction Biology 2013.
48. Froeliger B, Modlin L, Wang L, et al. Nicotine withdrawal modulates frontal brain function during an affective Stroop task. Psychopharmacology (Berl). 2012;220:707–18.
49. Rose EJ, Ross TJ, Salmeron BJ, et al. Acute nicotine differentially impacts anticipatory valence- and magnitude-related striatal activity. Biol Psychiatry. 2013;73:280–8.
50. Hartwell KJ, Lematty T, McRae-Clark AL, et al. Resisting the urge to smoke and craving during a smoking quit attempt on varenicline: results from a pilot fMRI study. Am J Drug Alcohol Abuse. 2013;39:92–8.
51. Kochunov P, Du X, Moran LV, et al. Acute nicotine administration effects on fractional anisotropy of cerebral white matter and associated attention performance. Front Parmacology. 2013;4:117.
52. Gazdzinski S, Durazzo TC, Mon A, et al. Cerebral white matter recovery in abstinent alcoholics—a multimodality magnetic resonance study. Brain. 2010;133:1043–53.
53. Wang GJ, Smith L, Volkow ND, et al. Decreased dopamine activity predicts relapse in methamphetamine abusers. Mol Psychiatry. 2011;17:918–25.
54. Groman SM, Lee B, Seu E, et al. Dysregulation of D2-mediated dopamine transmission in monkeys after chronic escalating methamphetamine exposure. J Neurosci. 2012;32:5843–52.
55. Groman SM, Morales AM, Lee B, et al. Methamphetamine-induced increases in putamen gray matter associate with inhibitory control. Psychopharmacology 2013: 1-12.
56. Boileau I, Payer D, Houle S, et al. Higher binding of the dopamine D3 receptor-preferring ligand [11C]-(+)-propyl-hexahydro-naphtho-oxazin in methamphetamine polydrug users: a positron emission tomography study. J Neurosci. 2012;32:1353–9.
57. 11C] raclopride study in humans. Br J Psychiatry. 2011;199:391–7.
58. Michaelides M, Thanos PK, Kim R, et al. PET imaging predicts future body weight and cocaine preference. Neuroimage. 2012;59:1508–13.
59. Volkow ND, Tomasi D, Gene-Jack W, et al. Reduced metabolism in brain “control networks” following cocaine-cues exposure in female cocaine abusers. PLoS ONE. 2011;6:e16573.
60. 11C]ABP688 and magnetic resonance spectroscopy. Biol Psychiatry 2013; in press.
61. Mackey S, Paulus M. Are there volumetric brain differences associated with the use of cocaine and amphetamine-type stimulants? Neurosci Biobehavl Rev. 2012;37:300–16.
62. Mandeville JB, Choi J-K, Jarraya B, et al. FMRI of cocaine self-administration in macaques reveals functional inhibition of basal ganglia. Neuropsychopharmacology. 2011;36:1187–98.
63. Salo R, Fassbender C, Buonocore MH, et al. Behavioral regulation in methamphetamine abusers: an fMRI study. Psychiatry Res Neuroimaging 2012.
64. Nestor LJ, Ghahremani DG, Monterosso J, et al. Prefrontal hypoactivation during cognitive control in early abstinent methamphetamine-dependent subjects. Psychiatry Res Neuroimaging. 2011;194:287–95.
65. Prisciandaro JJ, McRae-Clark AL, Myrick H, et al. Brain activation to cocaine cues and motivation/treatment status. Addiction Biology 2012.
66. Salo R, Buonocore MH, Leamon M, et al. Extended findings of brain metabolite normalization in MA-dependent subjects across sustained abstinence: A proton MRS study. Drug Alcohol Dep. 2011;113:133–8.
67. 1H MR spectroscopy study. Addict Biol. 2013;17(1):100–2.
68. Sung Y-H, Yurgelun-Todd DA, Shi X-F, et al. Decreased frontal lobe phosphocreatine levels in methamphetamine users. Drug Alcohol Dep. 2012;129:102–9.
69. Sung Y-H, Carey PD, Stein DJ, et al. Decreased frontal N-acetylaspartate levels in adolescents concurrently using both methamphetamine and marijuana. Behav Brain Res. 2013;6C:80–6.
70. 3 receptor availability is inversely correlated with cannabis consumption in chronic marijuana users. Drug Alcohol Dep. 2012;128:52–7.
71. 11C]-(+)-PHNO. Neuropsychopharmacology. 2012;38:673–82.
72. Hirvonen J, Goodwin R, Li C, et al. Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers. Mol Psychiatry. 2011;17:642–9.
73. Neumeister A, Normandin M, Pietrzak R, et al. Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study. Molecular Psychiatry 2013.
74. Gruber SA, Dahlgren MK, Sagar KA, et al. Worth the wait: effects of age of onset of marijuana use on white matter and impulsivity. Psychopharmacology 2013.
75. Cousijn J, Wiers RW, Ridderinkhof KR, et al. Grey matter alterations associated with cannabis use: results of a VBM study in heavy cannabis users and healthy controls. Neuroimage. 2012;59:3845–51.
76. King GR, Ernst T, Deng W, et al. Altered brain activation during visuomotor integration in chronic active cannabis users: relationship to cortisol levels. J Neurosci. 2011;31:17923–31.
77. Winton-Brown TT, Allen P, Bhattacharrya S, et al. Modulation of auditory and visual processing by delta-9-tetrahydrocannabinol and cannabidiol: an FMRI study. Neuropsychopharmacology. 2011;36:1340–8.
78. Smith AM, Zunini RAL, Anderson CD, et al. Impact of marijuana on response inhibition: an fMRI study in young adults. J Behav Brain Sci. 2011;1:124–33.
79. Wesley MJ, Hanlon CA, Porrino LJ. Poor decision-making by chronic marijuana users is associated with decreased functional responsiveness to negative consequences. Psychiatry Res Neuroimaging. 2011;191:51–9.
80. Sneider J, Mashhoon Y, Silveri M. A review of magnetic resonance spectroscopy studies in marijuana using adolescents and adults. J Addict Res Ther S. 2013;4:2.
81. Silveri MM, Jensen JE, Rosso IM, et al. Preliminary evidence for white matter metabolite differences in marijuana-dependent young men using 2D J-resolved magnetic resonance spectroscopic imaging at 4 Tesla. Psychiatry Res Neuroimaging. 2011;191:201–11.
82. Mashhoon Y, Jensen J, Sneider J, et al. Lower left thalamic myo-inositol levels associated with greater cognitive impulsivity in marijuana-dependent young men: preliminary spectroscopic evidence at 4 T. J Addict Res Ther S. 2013;4:2.
83. 2 receptors and presynaptic dopamine in heroin dependence: commonalities and differences with other types of addiction. Biol Psychiatry. 2012;71:192–8.
84. Moreno-López L, Stamatakis EA, Fernández-Serrano MJ, et al. Neural correlates of the severity of cocaine, heroin, alcohol, MDMA and cannabis use in polysubstance abusers: a resting-PET brain metabolism study. PLoS One. 2012;7:e39830.
85. Bora E, Yücel M, Fornito A, et al. White matter microstructure in opiate addiction. Addict Biol. 2013;17:141–8.
86. Qiu Y, Jiang G, Su H, et al. Progressive white matter microstructure damage in male chronic heroin dependent individuals: a DTI and TBSS study. PLoS One. 2013;8:e63212.
87. Schmidt A, Walter M, Gerber H, et al. Inferior frontal cortex modulation with an acute dose of heroin during cognitive control. Neuropsychopharmacology. 2013;38(11):2231–9.
88. Hermann D, Frischknecht U, Heinrich M, et al. MR spectroscopy in opiate maintenance therapy: association of glutamate with the number of previous withdrawals in the anterior cingulate cortex. Addict Biol. 2011;17:659–67.
89. Verdejo-García A, Lubman DI, Roffel K, et al. Cingulate biochemistry in heroin users on substitution pharmacotherapy. Aust N Z J Psychiatry. 2013;47:244–9.
90. Frischknecht U, Hermann D, Heinrich M, et al. Experience of social discrimination correlates with neurometabolism: a pilot study in heroin addicts. Eur Arch Psyc Clin Neurosci. 2012;263:197–203.
91. Domino EF, Minoshima S, Guthrie S, et al. Nicotine effects on regional cerebral blood flow in awake, resting tobacco smokers. Synapse. 2000;38:313–21.
92. Zubieta J-K, Lombardi U, Minoshima S, et al. Regional cerebral blood flow effects of nicotine in overnight abstinent smokers. Biol Psychiatry. 2001;49:906–13.
93. Domino EF, Ni L, Xu Y, et al. Regional cerebral blood flow and plasma nicotine after smoking tobacco cigarettes. Prog Neuro-Psychopharm Biol Psychiatry. 2004;28:319–27.
94. Kubota K, Yamaguchi T, Abe Y, et al. Effects of smoking on regional cerebral blood flow in neurologically normal subjects. Stroke. 1983;14:720–4.
95. Skinhϕj E, Olesen J, Paulson O. Influence of smoking and nicotine on cerebral blood flow and metabolic rate of oxygen in man. J App Physiology. 1973;35:820–2.
96. Gundersen H, van Wageningen H, Gruner R. Alcohol-induced changes in cerebral blood flow and cerebral blood volume in social drinkers. Alcohol Alcohol. 2013;48:160–5.
97. Volkow ND, Mullani N, Gould L, et al. Effects of acute alcohol intoxication on cerebral blood flow measured with PET. Psychiatry Res. 1988;24:201–9.
98. Sano M, Wendt PE, Wirsén A, et al. Acute effects of alcohol on regional cerebral blood flow in man. J Stud Alcohol Drugs. 1993;54:369.
99. Schwartz JA, Speed NM, Gross MD, et al. Acute effects of alcohol administration on regional cerebral blood flow: the role of acetate. Alcohol Clin Exp Res. 1993;17:1119–23.
100. Mathew R, Wilson W. Regional cerebral blood flow changes associated with ethanol intoxication. Stroke. 1986;17:1156–9.
101. Lotfi J, Meyer J. Cerebral hemodynamic and metabolic effects of chronic alcoholism. Cerebrovasc Brain Metab Rev. 1989;1:2–25.
102. Christie IC, Price J, Edwards L, et al. Alcohol consumption and cerebral blood flow among older adults. Alcohol. 2008;42:269–75.
103. Melgaard B, Henriksen L, Ahlgren P, et al. Regional cerebral blood flow in chronic alcoholics measured by single photon emission computerized tomography. Acta Neurol Scand. 1990;82:87–93.
104. Berglund M, Risberg J. Regional cerebral blood flow during alcohol withdrawal. Arch Gen Psychiatry. 1981;38:351–5.
105. Caspari D, Trabert W, Heinz G, et al. The pattern of regional cerebral blood flow during alcohol withdrawal‐a single photon emission tomography study with 99mTc‐HMPAO. Acta Psychiatr Scand. 1993;87:414–7.
106. Tutus A, Kuğu N, Sofuoğlu S, et al. Transient frontal hypoperfusion in Tc-99 m hexamethylpropyleneamineoxime single photon emission computed tomography imaging during alcohol withdrawal. Biol Psychiatry. 1998;43:923–8.
107. Ances BM, Vaida F, Cherner M, et al. HIV and chronic methamphetamine dependence affect cerebral blood flow. J Neuroimmune Pharmacol. 2011;6:409–19.
108. Broadley KJ. The vascular effects of trace amines and amphetamines. Pharmacol Ther. 2010;125:363–75.
109. Chung YA, Peterson BS, Yoon SJ, et al. In vivo evidence for long-term CNS toxicity, associated with chronic binge use of methamphetamine. Drug Alcohol Dep. 2010;111:155–60.
110. Polesskaya O, Silva J, Sanfilippo C, et al. Methamphetamine causes sustained depression in cerebral blood flow. Brain Res. 2011;1373:91–100.
111. Yuan Z, Luo Z, Volkow ND, et al. Imaging separation of neuronal from vascular effects of cocaine on rat cortical brain in vivo. Neuroimage. 2011;54:1130–9. Neuronal and vascular effects can be difficult to deconvolve with neuroimaging and is likely to confound results in many cases. This study demonstrates the importance of that notion.